165 related articles for article (PubMed ID: 17960581)
1. Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin.
Gharbi S; Garzón B; Gayarre J; Timms J; Pérez-Sala D
J Mass Spectrom; 2007 Nov; 42(11):1474-84. PubMed ID: 17960581
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
Stamatakis K; Sánchez-Gómez FJ; Pérez-Sala D
J Am Soc Nephrol; 2006 Jan; 17(1):89-98. PubMed ID: 16291835
[TBL] [Abstract][Full Text] [Related]
3. A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification.
Garzón B; Gayarre J; Gharbi S; Díez-Dacal B; Sánchez-Gómez FJ; Timms JF; Pérez-Sala D
Chem Biol Interact; 2010 Jan; 183(1):212-21. PubMed ID: 19800325
[TBL] [Abstract][Full Text] [Related]
4. Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity.
Díez-Dacal B; Gayarre J; Gharbi S; Timms JF; Coderch C; Gago F; Pérez-Sala D
Cancer Res; 2011 Jun; 71(12):4161-71. PubMed ID: 21507934
[TBL] [Abstract][Full Text] [Related]
5. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione.
Gayarre J; Stamatakis K; Renedo M; Pérez-Sala D
FEBS Lett; 2005 Oct; 579(25):5803-8. PubMed ID: 16223487
[TBL] [Abstract][Full Text] [Related]
6. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective.
Renedo M; Gayarre J; García-Domínguez CA; Pérez-Rodríguez A; Prieto A; Cañada FJ; Rojas JM; Pérez-Sala D
Biochemistry; 2007 Jun; 46(22):6607-16. PubMed ID: 17489560
[TBL] [Abstract][Full Text] [Related]
7. Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro.
Gayarre J; Avellano MI; Sánchez-Gómez FJ; Carrasco MJ; Cañada FJ; Pérez-Sala D
Ann N Y Acad Sci; 2007 Jan; 1096():78-85. PubMed ID: 17405918
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
Sánchez-Gómez FJ; Gayarre J; Avellano MI; Pérez-Sala D
Arch Biochem Biophys; 2007 Jan; 457(2):150-9. PubMed ID: 17169324
[TBL] [Abstract][Full Text] [Related]
9. Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid-protein interactomes.
Stamatakis K; Pérez-Sala D
Ann N Y Acad Sci; 2006 Dec; 1091():548-70. PubMed ID: 17341644
[TBL] [Abstract][Full Text] [Related]
10. Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function.
Oeste CL; Pérez-Sala D
Mass Spectrom Rev; 2014; 33(2):110-25. PubMed ID: 23818260
[TBL] [Abstract][Full Text] [Related]
11. Identification of the RelA domain responsible for action of a new NF-kappaB inhibitor DHMEQ.
Watanabe M; Nakashima M; Togano T; Higashihara M; Watanabe T; Umezawa K; Horie R
Biochem Biophys Res Commun; 2008 Nov; 376(2):310-4. PubMed ID: 18782563
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines.
Meier BW; Gomez JD; Zhou A; Thompson JA
Chem Res Toxicol; 2005 Oct; 18(10):1575-85. PubMed ID: 16533022
[TBL] [Abstract][Full Text] [Related]
13. Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins.
Díez-Dacal B; Sánchez-Gómez FJ; Sánchez-Murcia PA; Milackova I; Zimmerman T; Ballekova J; García-Martín E; Agúndez JA; Gharbi S; Gago F; Stefek M; Pérez-Sala D
Mol Pharmacol; 2016 Jan; 89(1):42-52. PubMed ID: 26487510
[TBL] [Abstract][Full Text] [Related]
14. Rac1 regulates heat shock responses by reorganization of vimentin filaments: identification using MALDI-TOF MS.
Lee SY; Song EJ; Kim HJ; Kang HJ; Kim JH; Lee KJ
Cell Death Differ; 2001 Nov; 8(11):1093-102. PubMed ID: 11687887
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometric identification of covalent adducts of the skin allergen 2,4-dinitro-1-chlorobenzene and model skin proteins.
Aleksic M; Pease CK; Basketter DA; Panico M; Morris HR; Dell A
Toxicol In Vitro; 2008 Aug; 22(5):1169-76. PubMed ID: 18440195
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
[TBL] [Abstract][Full Text] [Related]
17. A-class prostaglandins: early findings and new perspectives for overcoming tumor chemoresistance.
Díez-Dacal B; Pérez-Sala D
Cancer Lett; 2012 Jul; 320(2):150-7. PubMed ID: 22407242
[TBL] [Abstract][Full Text] [Related]
18. Dehydroalanine derived from cysteine is a common post-translational modification in human serum albumin.
Bar-Or R; Rael LT; Bar-Or D
Rapid Commun Mass Spectrom; 2008; 22(5):711-6. PubMed ID: 18265430
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry.
Reyes G; Naydenova Z; Abdulla P; Chalsev M; Villani A; Rose JB; Chaudary N; DeSouza L; Siu KW; Coe IR
Protein Expr Purif; 2010 Sep; 73(1):1-9. PubMed ID: 20399865
[TBL] [Abstract][Full Text] [Related]
20. Proteomic studies on protein modification by cyclopentenone prostaglandins: expanding our view on electrophile actions.
Garzón B; Oeste CL; Díez-Dacal B; Pérez-Sala D
J Proteomics; 2011 Oct; 74(11):2243-63. PubMed ID: 21459170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
